{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:08:57Z","timestamp":1777633737746,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.carrev.2019.04.023","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T11:22:23Z","timestamp":1556191343000},"page":"717-722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"21","author":[{"given":"Paul M.","family":"Ndunda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohinder R.","family":"Vindhyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabitha M.","family":"Muutu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaher","family":"Fanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2019.04.023_bb0005","doi-asserted-by":"crossref","unstructured":"Nishimura RA, Otto CM, Bonow RO et al. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e1159-e1195.","DOI":"10.1161\/CIR.0000000000000503"},{"key":"10.1016\/j.carrev.2019.04.023_bb0010","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1202277","article-title":"Transcatheter aortic-valve replacement for inoperable severe aortic stenosis","volume":"366","author":"Makkar","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.04.023_bb0015","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.04.023_bb0020","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.04.023_bb0025","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.04.023_bb0030","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.carrev.2019.04.023_bb0035","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.carrev.2019.04.023_bb0040","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.04.023_bb0045","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/clc.22328","article-title":"Stroke after transcatheter aortic valve replacement: incidence, risk factors, prognosis, and preventive strategies","volume":"37","author":"Mastoris","year":"2014","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.carrev.2019.04.023_bb0050","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.jacc.2011.08.024","article-title":"Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review","volume":"58","author":"Daneault","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.04.023_bb0055","doi-asserted-by":"crossref","unstructured":"Holmes DR, Jr., Mack MJ, Kaul S et al. 2012 ACCF\/AATS\/SCAI\/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Thorac Cardiovasc Surg 2012;144:e29\u201384.","DOI":"10.1002\/ccd.24351"},{"key":"10.1016\/j.carrev.2019.04.023_bb0060","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jacc.2011.08.050","article-title":"Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry","volume":"58","author":"Moat","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.04.023_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4244\/EIJV8I1A20","article-title":"Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients","volume":"8","author":"Eggebrecht","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2019.04.023_bb0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.tcm.2018.01.007","article-title":"Cerebral protection devices during transcatheter aortic valve implantation","volume":"28","author":"Vlastra","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.carrev.2019.04.023_bb0075","unstructured":"Claret Medical. Claret Medical receives FDA clearance to market Sentinel Cerebral Protection System in the U.S. Retrieved: http:\/\/www.claretmedical.com\/pdf\/news\/FDA%20Approval.pdf. 2017."},{"key":"10.1016\/j.carrev.2019.04.023_bb0080","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/STROKEAHA.116.015915","article-title":"Cerebral embolic protection devices during transcatheter aortic valve implantation systematic review and meta-analysis","volume":"48","author":"Bagur","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.carrev.2019.04.023_bb0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jacc.2016.10.023","article-title":"Protection against cerebral embolism during transcatheter aortic valve replacement","volume":"69","author":"Kapadia","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.04.023_bb0090","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jama.2016.10302","article-title":"Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial","author":"Haussig","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2019.04.023_bb0095","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.jcin.2017.06.037","article-title":"Cerebral embolic protection during transcatheter aortic valve replacement significantly reduces death and stroke compared with unprotected procedures","volume":"10","author":"Seeger","year":"2017","journal-title":"Jacc-Cardiovascular Interventions"},{"key":"10.1016\/j.carrev.2019.04.023_bb0100","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/CIRCULATIONAHA.112.001091","article-title":"Histopathology of embolic debris captured during transcatheter aortic valve replacement","volume":"127","author":"Van Mieghem","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2019.04.023_bb0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4244\/EIJV12I4A84","article-title":"Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial","volume":"12","author":"Van Mieghem","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2019.04.023_bb0110","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2019.04.023_bb0115","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.carrev.2019.04.023_bb0120","unstructured":"Higgins J, Sterne J, Savovi\u0107 J et al. A revised tool for assessing risk of bias in randomized trials In: Chandler J, McKenzie J, Boutron I, Welch V (editors). Cochrane Methods. Cochrane Database Syst Rev 2016:Supp 1."},{"key":"10.1016\/j.carrev.2019.04.023_bb0125","first-page":"i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Clinical research ed"},{"issue":"7 Pt A","key":"10.1016\/j.carrev.2019.04.023_bb0130","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.carrev.2018.02.009","article-title":"Safety and efficacy of cerebral protection devices in transcatheter aortic valve replacement: a clinical end-points meta-analysis","volume":"19","author":"Mohananey","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2019.04.023_bb0135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jacc.2016.12.002","article-title":"Cerebral embolic protection during TAVR: a clinical event meta-analysis","volume":"69","author":"Giustino","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.04.023_bb0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijcard.2016.06.143","article-title":"Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: a systematic review and meta-analysis","volume":"221","author":"Pagnesi","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2019.04.023_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/heartjnl-2011-300065","article-title":"Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status","volume":"98","author":"Fairbairn","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2019.04.023_bb0150","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003284","article-title":"Embolic protection devices in transcatheter aortic valve replacement","volume":"9","author":"Steinvil","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.04.023_bb0155","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jcin.2018.06.018","article-title":"Significant differences in debris captured by the sentinel dual-filter cerebral embolic protection during transcatheter aortic valve replacement among different valve types","volume":"11","author":"Seeger","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.04.023_bb0160","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jcin.2018.03.001","article-title":"Debris heterogeneity across different valve types captured by a cerebral protection system during transcatheter aortic valve replacement","volume":"11","author":"Schmidt","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.04.023_bb0165","doi-asserted-by":"crossref","unstructured":"Seeger JG, B.; Otto, M.; Rottbauer, W.; W\u00f6hrle, J. TCT-4 Reduction of stroke with use of the double-filter cerebral embolic protection device in patients undergoing transfemoral aortic valve replacement with self-expandable, mechanically implantable and balloon-expandable aortic valves. TCT 2018. San Diego, CA, USA, 2018.","DOI":"10.1016\/j.jacc.2018.08.1079"},{"key":"10.1016\/j.carrev.2019.04.023_bb0170","series-title":"EuroPCR","article-title":"M.B.; Kapadia, S.; Kodali, S.; Mehran, R.; Linke, A.; Makkar, R.R. Anatomical predictors of stroke prevention during transcatheter aortic valve implantation: the SENTINEL Trial","volume":"vol. 2018","author":"Jilaihawi","year":"2018"},{"issue":"4","key":"10.1016\/j.carrev.2019.04.023_bb0175","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.athoracsur.2018.11.013","article-title":"Development and application of a risk prediction model for in-hospital stroke after transcatheter aortic valve replacement: a report from the Society of Thoracic Surgeons\/American College of Cardiology Transcatheter Valve Therapy Registry","volume":"104","author":"Thourani","year":"2018","journal-title":"Ann Thorac Surg"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383891930257X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383891930257X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:16:36Z","timestamp":1761560196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155383891930257X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S155383891930257X"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.04.023","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}